A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee

Alan Kivitz, Carl Ma, Harry Ahdieh, Bradley S. Galer

Clinical Therapeutics · 2006 · 83 citations · 32 references

Concepts

References

32